Partner Amy Baker Mandragouras will moderate an upcoming CvilleBioHub panel, “Eye on the Exit: Building Early-Stage Enterprise Value.” The panel will discuss their experiences building, managing, and exiting startups, including:
- What key factors make an early-stage company successful and attractive to investors?
- In the entrepreneurial rush to develop a minimum viable product, what management “distractions” should founders actually focus on to increase their odds of success? What shortcuts are counterproductive?
- What communications strategy should science-oriented founders follow to communicate effectively with business and financial partners?
Co-panelists for the event include Evan Edwards, CIO at Kymanox, Chad Rodgers, Founder of TypeZero, Lisa Bowers, Executive in Residents at UVA’s Licensing and Ventures Group, and Andy Krouse, President and CEO of Slate Bio.
CvilleBioHub accelerates the development and commercialization of innovative biotech and medtech solutions by connecting entrepreneurs, scientists and investors, providing access to funding and resources, and advocating for policies that support life sciences. It is the leading catalyst for the growth and development of the biotech, medtech, and life sciences ecosystem in Charlottesville and Central Virginia, fostering a vibrant and collaborative environment where all companies can thrive and grow.
